Larynx squamous cell carcinoma: Concepts and future directions

Surgical Oncology Clinics of North America

Volumn 13, Issue 1, 2004, Pages 99-112

  Mojica Manosa, Pablo ^a   Reidy, James ^a   Wilson, Keith ^b   Douglas, Wade ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON; CARCINOGEN; NITROSAMINE;

ALCOHOL CONSUMPTION; BONE METASTASIS; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DERMATITIS; DIETARY INTAKE; FISTULA; GASTRITIS; HEAD AND NECK CARCINOMA; HEMATOMA; HIGH SODIUM INTAKE; HUMAN; LARYNGECTOMY; LARYNGOSCOPY; LARYNX CARCINOMA; LARYNX SURGERY; LIPID DIET; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; METASTASIS; MOUTH CARCINOMA; MUCOSA INFLAMMATION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PNEUMONIA; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; SEROMA; SMOKING; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; THYROID DISEASE; WOUND INFECTION; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 1542357320     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00130-3     Document Type: Review

References (68)

1. Greenle R., Hill-Herman M., Murray T., et al. Cancer statistics, 2001. CA Cancer J Clin. 51:2001;15.
2. Austen D. Larynx. Schottenfeld D., Fraumani J. Cancer epidemiology and prevention. 1982;WB Saunders, Philadelphia.
3. International Agency for Research on Cancer. Tobacco smoking: IARC monograph on the evaluation of the carcinogenic risk of chemicals to humans. 1986;IARC, Washington, DC.
4. Morse D., Katz R., Pendrys D., et al. Smoking and drinking in relation to oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev. 5:1996;769.
5. Spitz M., Fueger J., Goepfert H., et al. Squamous cell carcinoma of the upper aerodigestive tract: a case comparison analysis. Cancer. 61:1988;203.
6. Falk R., Pickle L., Brown L., et al. Effect of smoking and alcohol consumption on laryngeal cancer risk. Cancer Res. 49:1989;4024.
7. Hedberg K., Vaughn T., White E., et al. Alcoholism and cancer of the larynx: a case control study in western Washington. Cancer Causes Control. 5:1994;3.
8. Sinard R., Netterville J., et al. Cancer of the larynx. Myers E., Suen J. Cancer of the head and neck. 1996;WB Saunders, Philadelphia.
9. Weinstein G., Brunn D., Laccourreye H. Larynx anatomy: surgical and clinical implications. Weinstein G., Laccourreye H., Laccourreye O. Organ preservation surgery. 2000;Singular Publishing Group, San Diego, CA.
10. Redaelli de Zinis L., Nicolai P., Barezzani M., et al. Incidence and distribution of lymph node metastases in supraflottic squamous cell carcinoma: therapeutic implications. Acta Otorhinolaryngol Ital. 14:1994;19.
11. Bocca E., Pignataro O., Oldini C. Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol. 92:1983;14.
12. Johnson J., Myers E. Cervical lymph node disease in laryngeal cancer. Silver C. Laryngeal cancer. 1991;Thieme, New York.
13. Robbins K., Medina J., Wolfe G., et al. Standarizing neck dissection terminology. Arch Otolaryngol Head Neck Surg. 117:1991;601.
14. Mukherji S., Armao D., Joshi V. Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect. Head Neck. 23:2001;995.
15. Candela F., Shah J., Jacques D., et al. Patterns of cervical node metastases from squamous cell carcinoma of the larynx. Arch Otolaryngol Head Neck Surg. 116:1990;432.
16. Marks J., Breaux S., Smith P., et al. The need for elective radiation of occult lymphatic metastases from cancer of the larynx and pyriform sinus. Head Neck. 8:1985;3.
17. Lamprecht J., Lamprecht A., Kurten-Rothes R. Mediastinal involvement in cancer of the subglottis, hypopharynx and cervical esophagus. Laryngorhinootologie. 66:1987;88.
18. Merino O., Lindburg R., Fletcher G. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 40:1977;145.
19. Roviresa A., Bellmunt J., Lopez A., et al. The incidence of second neoplasm in advance laryngeal cancer: impact on survival. Medicina Clinica Rovirosa. 102:1994;121-124.
20. Greene F., Page D., Fleming I., et al. AJCC cancer staging manual. 6th edition:2002;Springer-Verlag, New York.
21. Shah J., Karnell L., Hoffman H., et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg. 123:1997;475.
22. Myers E., Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts and future trends. Laryngoscope. 106:1996;559.
23. Nguyen T., Malissard L., Theobald S., et al. Advance carcinoma of the larynx: results of surgery and radiotherapy without induction chemotherapy (1980-1985): a multivariate analysis. Int J Radiat Oncol Biol Phys. 36:1996;1013.
24. Brasilino de Carvalho M. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head and Neck. 20:(1):1998(Jan);16-21.
25. Gandour-Edwards E., Donald P., Yu T., et al. DNA content of head and neck squamous cell carcinoma by flow cytometry. Otolaryngol Head Neck Surg. 120:1994;294.
26. Wolf G., Fisher S., Truelson J., et al. DNA content and regional metastases in patients with advance laryngeal squamous carcinoma. Department of Veterans Affairs Laryngeal Study Group. Laryngoscope. 104:1994;479.
27. Haughey B., Von Hoff D., Windle B., et al. c-Myc oncogene copy number in squamous cell carcinoma of the head and neck. Am J Otolaryngol. 13:1992;168.
28. Somers K., Cartwright S., Schecther G. Amplifications of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene. 5:1990;915.
29. Anwar K., Nakakuki I., Imai H., et al. Overexpression of p53 protein in human laryngeal cancer. Int J Cancer. 53:1993;952.
30. Cummings C., Fredrickson J., Harker L., et al. Otolaryngology - head and neck surgery. 1998;Mosby Year Book, Inc. St. Louis (MO).
31. Zbaren P., Becker M., Lang H. Pretherapeutic staging of laryngeal carcinoma. Clinical findings, computed tomography and magnetic resonance imaging compared with histopathology. Cancer. 77:1996;1263.
32. Becker M., Zbaren P., Lang H., et al. Neoplastic invasion of laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 194:1995;661.
33. Fischbein N., Aassar O., Caputo G., et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 19:1998;1189.
34. Escott E., Reo V., Lo M., et al. Comparison of dynamic contrast-enchanced gradient-echo and spin-echo sequences in MR of head and neck neoplasm. AJNR Am J Neuroradiol. 18:1997;1411.
35. Lydiatt W., Lydiatt D. The larynx: early stage disease. Shah J., Patel S. Cancer of the head and neck. 2001;BC Becker, London.
36. Thompson L., Weing B., Heffnar D., et al. Exophytic and papillary squamous cell carcinomas of the larynx: a clinicopathologic series of 104 cases. Otolaryngol Head Neck Surg. 120:1999;718.
37. Lutz C., Wagner R., Johnson J., et al. Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhino Laryngol. 99:1990;12.
38. Robson N., Oswal V., Flood L. Radiation therapy of laryngeal cancer: a twenty year experience. J Laryngol Otol. 104:1990;699.
39. Ton-Van J., Lefebvre J., Stern J., et al. Comparison of surgery and radiotherapy in T1 and T2 glottic carcinomas. Am J Surg. 162:1991;337-340.
40. Burke L., Grever K., McGuirt W., et al. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys. 38:1997;37-42.
41. Wolf G., Fisher S., Hong W., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advance laryngeal cancer. VA Laryngeal Cancer Study Group. N Engl J Med. 324:1991;1685-1690.
42. Harwood A., DeBoer G. Prognostic factors in T2 glottic cancer. Cancer. 45:1980;991.
43. Kersch C., Kelly M., Hanh S., et al. Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy. South Med J. 83:1990;373.
44. Daly C., Strong E. Carcinoma of the glottic larynx. Am J Surg. 130:1975;489-493.
45. Hawkins N. The treatment of glottic carcinoma: an analysis of 800 cases. Laryngoscope. 85:1975;1485-1493.
46. Jesse R. The evaluation and treatment of patients with extensive squamous cell carcinoma of the vocal cords. Laryngoscope. 85:1975;1424.
47. Clayman G., Frank D. Selective neck dissection of anatomically appropriate levels is as efficacious as modified radical neck dissection for elective treatment of the clinically negative neck in patients with squamous cell carcinoma of the upper respiratory and digestive tracts. Arch Otolaryngol Head Neck Surg. 124:1998;348.
48. Candela F., Shah J., Jaques D., et al. Patterns of cervical node metastases from squamous cell carcinoma of the larynx. Arch Otolaryngol Head Heck Surg. 116:1990;432.
49. Brentani R., Kowalski L., Soares J., et al. End results of a prospective trial on elective lateral neck dissection vs. type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck. 21:1999;694.
50. Bezick A., Grilli R., Browman G. Non-rectability in radiotherapy trials in squamous cell carcinoma of the head and neck: implications for generalizability of trials results. Proceedings American Society of Clinical Oncology. 14:1995;296.
51. Soo K., Shah J., Gopinath K., et al. Analysis of prognostic variables and results after supraglottic partial laryngectomy. Am J Surg. 156:1988;301-305.
52. Wanebo H., Chongule P., Akerley W., et al. Pre-operative chemoradiation coupled with aggressive resection as needed ensures near total control in advance head and neck cancer. Am J Surg. 174:1997;518.
53. Mantz C., Vokes E., Kies M., et al. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of loco-regionally advance laryngeal cancer. Ann Oncol. 12:2001;343.
54. Fornari G., Artusio E., Mairone L., et al. Paclitaxel and carboplatin in neoadjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma. Tumori. 88:2002;489.
55. Taylor S., Murthy A., Vannetzel J., et al. Randomized comparison of neoadjuvant cisplatin and flourouracil infusion followed by radiation versus concomitant treatment in advance head and neck cancer. J Clin Oncol. 12:1994;385-395.
56. Jacobs C., Goffinet D., Goffinet L., et al. Chemotherapy as a substitute for surgery in the treatment of advance respectable head and neck cancer. A report from the Northern California Oncology Group. Cancer. 60:1987;1178.
57. Pfister D., Strong E., Harrison L., et al. Larynx preservation with combined chemotherapy and radiation therapy in advance but respectable head and neck cancer. J Clin Oncol. 9:1991;850-859.
58. Spaulding M., Fischer S., Wolf G., The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. Tumor response, toxicity and survival after neoadjuvant organ preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol. 12:1994;1592.
59. Shirinian M., Weber R., Lippman S., et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M.D. Anderson Cancer Center Experience. Head Neck. 16:1994;39.
60. Lazarus C., Logemann J., Punloski B., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 106:1996;1151-1166.
61. Weber P., Johnson J., Myers E. Impact of bilateral neck dissection on recovery following supraglottic laryngectomy. Arch Otolaryngol Head Neck Surg. 11:1993;61-64.
62. Lee N., Goepfert H., Wendt C. Supraglottic laryngectomy for intermediate-stage cancer: UTMD Anderson Cancer Center Experience with combined therapy. Laryngoscope. 100:1990;831.
63. Virtaniemi J., Kumpulainem E., Hirvikoski P., et al. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 23:2001;29.
64. Redaelli de Zinis L., Ferrari L., Tomenzoli D., et al. Post laryngectomy pharyngocutaneous fistulae: incidence, predisposing factors and therapy. Head Neck. 21:1999;131.
65. Parkish S., Irish J., Curran A., et al. Pharyngocutaneous fistula in laryngectomy patients: the Toronto hospital experience. J Otolaryngol. 27:1998;136.
66. Carew J. The larynx: advance stage disease. Shah J., Patel S. Cancer of the head and neck. 2001;BC Becker, London.
67. Mclaughlin M., Mendenhall W., Mancuso A., et al. Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck. 17:1995;190.
68. Nguyen-Tan P., Quynh-Thu L., Quivey J., et al. Treatment results and prognostic factors of advanced T3-4 laryngeal carcinoma: The University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Int J Radiat Oncol Biol Phys. 50:2001;1172.